Methemoglobinemia overview: Difference between revisions

Jump to navigation Jump to search
 
(32 intermediate revisions by 2 users not shown)
Line 4: Line 4:
{{Methemoglobinemia }}
{{Methemoglobinemia }}


{{CMG}}, {{AE}} {{Aksiniya K. Stevasarova}}
{{CMG}}, {{AE}}{{AKS}}


==Overview==   
==Overview==   
 
[[Methemoglobinemia]] is a blood disorder in which, due to increased production (congenital or acquired reasons), the [[red blood cells]] (RBCs) contain higher than normal levels of [[methemoglobin]] ([[MetHb]]) (>1%). [[Methemoglobin]] forms from the substitution of iron (Fe) in [[ferric/reduced (Fe<sup>2+</sup>) form]], as found in normal [[hemoglobin]], with iron in [[oxidized (Fe<sup>3+</sup>) form]]. The oxidation of [[Hb]] to [[MetHb]] ( Fe<sup>2+</sup> to Fe<sup>3+</sup> ) occurs naturally in healthy people, as a result of the interaction of [[Hb]] with [[oxygen free radicals]], which are produced during normal cell metabolism. The levels of [[MetHb]] though, never exceed more than 1%, if the protective [[reduction enzyme systems]] in the [[RBCs]] are working properly. [[Hemoglobin]] is the polypeptide protein in the RBCs, consisting of 2 alfa and 2 beta chains connected to an iron atom in ferric form, responsible for binding, carrying and distributing oxygen from the lungs to the tissues. [[MetHb]] is '''unable''' to bind oxygen, and in case of [[methemoglobinemia]], the affinity of the remaining normal Hb (that has not been yet oxidized to MetHb) to oxygen is very high. This leads to leftward shift of the [[oxygen-hemoglobin dissociation curve]], resulting in [[hypoxia]] and dyspnea, because no oxygen gets released to the tissues.
Methemoglobinemia is a blood disorder in which, due to increased production (congenital or acquired reasons), the red blood cells (RBCs) contain higher than normal levels of methemoglobin (MetHb) (>1%). Methemoglobin forms from the substitution of iron (Fe) in ferric/reduced (Fe<sup>2+</sup>) form, as found in normal hemoglobin, with iron in oxidized (Fe<sup>3+</sup>) form. The oxidation of Hb to MetHb ( Fe<sup>2+</sup> to Fe<sup>3+</sup> ) occurs naturally in healthy people, as a result of the interaction of Hb with oxygen free radicals, which are produced during normal cell metabolism. The levels of MetHb though, never exceed more than 1%, if the protective reduction enzyme systems in the RBCs are working properly.  
 
Hemoglobin is the polypeptide protein in the RBCs, consisting of 2 alfa and 2 beta chains connected to an iron atom in ferric form, responsible for binding, carrying and distributing oxygen from the lungs to the tissues. MetHb is '''unable''' to bind oxygen, and in case of methemoglobinemia, the affinity of the remaining normal Hb (that has not been yet oxidized to MetHb) to oxygen is very high. This leads to leftward shift of the oxygen-hemoglobin dissociation curve, resulting in hypoxia and dyspnea, because no oxygen gets released to the tissues. <ref>{{Rev Bras Anestesiol. 2008 Nov-Dec;58(6):651-64. Methemoglobinemia: from diagnosis to treatment.
[Article in English, Portuguese] do Nascimento TS1, Pereira RO, de Mello HL, Costa J. pmid=19082413}}</ref>
 
{{Reflist|2}}


==Classification==
==Classification==
 
Methemoglobinemia may be classified into two groups, based on the mechanism of its formation- acquired and congenital methemoglobinemia.
'''Congenital (Hereditary) Methemoglobinemia'''  <ref>{{Haematologia (Budap). 1982 Dec;15(4):389-99. Enzymopenic hereditary methemoglobinemia. Jaffé ER. pmid=PMID: 6764628}}</ref>   
 
{{Reflist|2}}
 
 
There are three main congenital conditions that lead to methemoglobinemia:
 
1. Cytochrome b5 reductase deficiency and pyruvate kinase deficiency
 
2. G6PD deficiency
 
3. Presence of abnormal hemoglobin (Hb M)
 
'''Acquired or Acute Methemoglobinemia''' <ref>{{Med Toxicol. 1986 Jul-Aug;1(4):253-60. Drug- and chemical-induced methaemoglobinaemia. Clinical features and management. Hall AH, Kulig KW, Rumack BH.pmid=PMID: 3537620}}</ref>
{{Reflist|2}}
 
 
The most common causes are different oxidant drugs, toxins and chemicals.


==Pathophysiology==
==Pathophysiology==
[[Methemoglobin]] (MetHb) refers to the state of [[hemoglobin]] ([[Hb]]) in which the [[iron atom)] is [[oxidized]] or in [[ferric state]] (Fe3+). In this state the [[iron]] is incapable of creating a bond with the [[oxygen]], thus it neither can bind, nor deliver [[oxygen]] to the tissues.The formation of [[methemoglobin]] can be a result of a normal physiologic process of losing an [[electron]] from the iron atom, after releasing the [[oxygen]] to the tissues, and we can detect [[methemoglobin]] in the blood of healthy people, but the normal levels should always be less than 1%. These levels are maintained by several [[enzyme systems]] that work to reduce the [[iron]] to its [[ferrous state]] (Fe2+).


==Causes==
==Causes==
 
Methemoglobinemia may be caused by either congenital or acquired conditions.
'''1. Drug Induced'''
 
• Anesthetics like benzocaine, lidocaine, prilocaine
 
• Methylene blue
 
• Nitric Oxide
 
• Amilnitrate
 
• Nitroglycerin
 
• Antimalarial drugs like Primaquine phosphate (in nicotinamide adenine dinucleotide (NADH) methemoglobin reductase deficient individuals)
 
• Rasburicase
 
• Sulfasalazine
 
• Dapsone
 
• Trimethoprim
 
• Sulfonamides
 
• Aniline dyes
 
• Metoclopramide
 
• Chlorates and Bromates
 
'''2.''' '''Contaminated well water''' (in premature infants and infants younger than 4 months)
 
'''3.''' '''Solid foods''' (not well cooked vegetables high in nitrates in premature infants and infants younger than 4 months)


==Differentiating {{PAGENAME}} from Other Diseases==
==Differentiating {{PAGENAME}} from Other Diseases==
 
Methemoglobinemia must be differentiated from other diseases that cause [[hypoxia]] and [[cyanosis]], such as [[heart failure]], [[pulmonary embolism]], [[polycythemia]], [[anemia]], etc.
Depending on the levels of MetHb in the blood we can observe different sympotoms as follows: MetHB 15 % presents with skin and blood color changes at levels, Levels above 15 % will result in hypoxia and levels above 70% can lead to death. 
 
There are several conditions that can present similar to methemoglobinemia. Note that the hypoxia in methemogobinemia will be unresponsive to oxygen treatment, in comparison to cardiac and pulmonary cause. Worth mentioning is that high doses of antidotal treatment for methemogobinemia (Methylene blue) can also cause cyanotic discoloration of the skin, but this does not mean the the treatment is not working.  
 
Differential Diagnoses
 
• Heart failure
 
• Pulmonary embolism
 
• Polycythemia
 
• Anemia
 
• Rasbirucase (Rx Tumor Lysis Syndrome)
 
• Metabolic Acidosis
 
• Methylene Blue treatment
 
• Sulfhemoglobin
 
• Asthma


==Epidemiology and Demographics==
==Epidemiology and Demographics==
The incidence of congenital methemoglobinemia in the United States is very low. There is no racial predilection to [[methemoglobinemia]]. The highest prevalence of [[G6PD deficiency]] is observed in the malaria-endemic regions: Sub-Saharan Afria, West Asia and Arabian Peninsula, as well as in people of Mediterranean descent.


==Risk Factors==
==Risk Factors==


==Screening==
==Screening==
[[Methemoglobinemia]] screening is not routinely done in the United States.


==Natural History, Complications, and Prognosis==
==Natural History, Complications, and Prognosis==
===Natural History===
===Natural History===
Depending on the causes that have led to methemoglobin formation, different complications and prognosis are expected respectively.


===Complications===
===Complications===
Death is the most serious complications of methemoglobinemia especially when [[MetHb]] levels approach 70%. In severely sick patients death may occur even with lower levels of [[MetHb]]. Other complications include [[myocardial infarction]], [[seizure]] and [[coma]]. <ref name="pmid14579544">{{cite journal| author=Bradberry SM| title=Occupational methaemoglobinaemia. Mechanisms of production, features, diagnosis and management including the use of methylene blue.


===Prognosis===
===Prognosis===
Depending on the [[anoxic end-organ damage]] caused by [[MetHb]], the prognosiss varies between mild and fatal.


==Diagnosis==
==Diagnosis==
Line 117: Line 43:


===History and Symptoms===
===History and Symptoms===
Methemoglobinemia will present with different signs and symptoms depending on the methemoglobin levels in the blood.


===Physical Examination===
===Physical Examination===


===Laboratory Findings===
===Laboratory Findings===
Methemoglobinemia can be diagnosed with several laboratory findings such as ABG analysis, co-oximetry and pulse oximetry.


===Imaging Findings===
===Imaging Findings===
Line 128: Line 56:
==Treatment==
==Treatment==
===Medical Therapy===
===Medical Therapy===
Methemoglobinemia should be promptly treated once diagnosed.


===Surgery===
===Surgery===
Surgery does not play a role in the treatment of Methemoglobinemia.


===Prevention===
===Prevention===
Line 137: Line 67:


[[Category:Hematology]]
[[Category:Hematology]]
{{WH}}
{{WS}}

Latest revision as of 22:08, 31 July 2018


Methemoglobinemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Methemoglobinemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Methemoglobinemia overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Methemoglobinemia overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Methemoglobinemia overview

on Methemoglobinemia overview

Methemoglobinemia overview in the news

Blogs on Methemoglobinemia overview

Directions to Hospitals Treating Methemoglobinemia

Risk calculators and risk factors for Methemoglobinemia overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Aksiniya Stevasarova, M.D.

Overview

Methemoglobinemia is a blood disorder in which, due to increased production (congenital or acquired reasons), the red blood cells (RBCs) contain higher than normal levels of methemoglobin (MetHb) (>1%). Methemoglobin forms from the substitution of iron (Fe) in [[ferric/reduced (Fe2+) form]], as found in normal hemoglobin, with iron in [[oxidized (Fe3+) form]]. The oxidation of Hb to MetHb ( Fe2+ to Fe3+ ) occurs naturally in healthy people, as a result of the interaction of Hb with oxygen free radicals, which are produced during normal cell metabolism. The levels of MetHb though, never exceed more than 1%, if the protective reduction enzyme systems in the RBCs are working properly. Hemoglobin is the polypeptide protein in the RBCs, consisting of 2 alfa and 2 beta chains connected to an iron atom in ferric form, responsible for binding, carrying and distributing oxygen from the lungs to the tissues. MetHb is unable to bind oxygen, and in case of methemoglobinemia, the affinity of the remaining normal Hb (that has not been yet oxidized to MetHb) to oxygen is very high. This leads to leftward shift of the oxygen-hemoglobin dissociation curve, resulting in hypoxia and dyspnea, because no oxygen gets released to the tissues.

Classification

Methemoglobinemia may be classified into two groups, based on the mechanism of its formation- acquired and congenital methemoglobinemia.

Pathophysiology

Methemoglobin (MetHb) refers to the state of hemoglobin (Hb) in which the [[iron atom)] is oxidized or in ferric state (Fe3+). In this state the iron is incapable of creating a bond with the oxygen, thus it neither can bind, nor deliver oxygen to the tissues.The formation of methemoglobin can be a result of a normal physiologic process of losing an electron from the iron atom, after releasing the oxygen to the tissues, and we can detect methemoglobin in the blood of healthy people, but the normal levels should always be less than 1%. These levels are maintained by several enzyme systems that work to reduce the iron to its ferrous state (Fe2+).

Causes

Methemoglobinemia may be caused by either congenital or acquired conditions.

Differentiating Methemoglobinemia overview from Other Diseases

Methemoglobinemia must be differentiated from other diseases that cause hypoxia and cyanosis, such as heart failure, pulmonary embolism, polycythemia, anemia, etc.

Epidemiology and Demographics

The incidence of congenital methemoglobinemia in the United States is very low. There is no racial predilection to methemoglobinemia. The highest prevalence of G6PD deficiency is observed in the malaria-endemic regions: Sub-Saharan Afria, West Asia and Arabian Peninsula, as well as in people of Mediterranean descent.

Risk Factors

Screening

Methemoglobinemia screening is not routinely done in the United States.

Natural History, Complications, and Prognosis

Natural History

Depending on the causes that have led to methemoglobin formation, different complications and prognosis are expected respectively.

Complications

Death is the most serious complications of methemoglobinemia especially when MetHb levels approach 70%. In severely sick patients death may occur even with lower levels of MetHb. Other complications include myocardial infarction, seizure and coma. <ref name="pmid14579544">{{cite journal| author=Bradberry SM| title=Occupational methaemoglobinaemia. Mechanisms of production, features, diagnosis and management including the use of methylene blue.

Prognosis

Depending on the anoxic end-organ damage caused by MetHb, the prognosiss varies between mild and fatal.

Diagnosis

Diagnostic Criteria

History and Symptoms

Methemoglobinemia will present with different signs and symptoms depending on the methemoglobin levels in the blood.

Physical Examination

Laboratory Findings

Methemoglobinemia can be diagnosed with several laboratory findings such as ABG analysis, co-oximetry and pulse oximetry.

Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Methemoglobinemia should be promptly treated once diagnosed.

Surgery

Surgery does not play a role in the treatment of Methemoglobinemia.

Prevention

References